| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |